FDA probes new cases of cancer that may stem from cancer cell therapies

The latest stories trending on MedCity News.

Editor's Pick

Top Story FDA Probes New Cases of Cancer That May Stem From Cancer Cell Therapies CAR T-therapies for cancer are now under tighter FDA scrutiny as the agency opens an inquiry regarding reports that some patients who received these cell therapies went on to develop new cases of cancer. The FDA said benefits of these therapies still outweigh their risks, but it is evaluating the need for regulatory action. Sponsored Content HealthBook+ CEO Shares Vision for How People Can Own Their Health by Leveraging Data and AI Presented by MedCity News & HealthBook+ HealthBook+ provides a way for individuals to aggregate and use their personal health information safely and securely to power AI engines that direct people to their next best health action. Importantly, it also gives employers predictive insights to help them provide the most relevant benefits for their employees. Learn More. Black Friday, Cyber Monday Savings Continue For You While the retail sales are over, you can still save $700 on your seat for INVEST 2024 taking place May 21-22 in Chicago at the Ritz. Don't miss out on these great savings and your opportunity to network with the best in healthcare and stay abreast of the latest industry trends and conversations. Hurry these savings only last until Dec 15th. Get My Savings Now

Featured News

Philips Launches New Cloud-Based PACS & Unveils Mobile MRI System Two of Philips' most notable RSNA announcements were that its new cloud-based PACS is available and that its helium-free mobile MRI system will soon be deployed. More than 80 sites across the U.S. and Latin America have already migrated to Philips' new PACS, and its mobile MRI system will be traveling to various cities next year. Report: How Does Medicaid Perform Compared To Other Forms of Coverage? A higher share of Medicaid beneficiaries rate their physical and mental health as fair or poor compared to adults with Medicare, employer-sponsored insurance or Marketplace coverage, according to a new KFF report. However, 83% of Medicaid enrollees gave their health insurance a positive rating. Integrated Technology Helps Nurses Make Time for the Moments That Matter If we can simplify nurses' work by embracing technology that streamlines, automates, and integrates processes like scheduling, credentialing, and compliance management to enhance quality outcomes, we can give nurses time back to spend on the moments that matter most. Season Health Expands Provider Network Through Strategic Asset Acquisition from Wellory By acquiring clinical assets from Wellory, Season Health will be able to greatly expand its provider network. The company will also gain national contracts with Aetna and Cigna. A New Deal for Hospitals Hospitals that are able to transform what they are and how they operate can survive and serve the public well. They will still require investments from society in the interim, but that investment will be justified by the public good and eventually represent a windfall to taxpayers. Virtual Data Rooms are Securing the Next Wave of Medical Research Advancements Developed as part of the due diligence process for the disclosure of confidential documents, VDRs provide a secure repository for all types of confidential materials including merger and acquisition (M&A) documents, financial statements, contracts, intellectual property details, and legal agreements. Why Consumers Should Care About Biomarkers — And How Technology Developers and Manufacturers Can Bridge the Gap More precise and consumer-friendly biomarker detection technologies are coming to market at a pace that can help users gain rich insight into their health and well-being from anywhere and at any time. This is especially important when it comes to preventive healthcare. Unmasking the Silent Epidemic: A Four-Point Plan to Tackle COPD COPD is the sixth leading cause of death—but more than 50% of those impacted don't even have a diagnosis. The so-called silent epidemic demands urgent action, as exorbitant costs and preventable deaths skyrocket. This four-point plan outlines a holistic strategy to address COPD. FDA Approval of SpringWorks Drug Is the First for Rare Connective Tissue Tumor SpringWorks Therapeutics drug Ogsiveo is now FDA-approved for treating desmoid tumors, a type of tumor affecting connective tissue. The regulatory decision makes the pill the first therapy approved specifically for treating this rare disorder. How the IRA Has Created a New Environment for Biosimilars As IRA provisions are activated, the law's impact on biologics and biosimilars will become more apparent. By using both the carrot and the stick, the IRA may finally bolster the market, increasing uptake of biosimilars to benefit patients and help lower costs.

Resources

MedCity Pivot Podcast: Health Equity in Opioid Addiction Treatment With Dr. Brian Clear Dr. Brian Clear, an addiction treatment physician and chief medical officer of Bicycle Health, believes that telemedicine is one way to improve access and reduce the inequities inherence in addiction treatment. The other is education. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe